Inmune Bio Inc. (INMB) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Inmune Bio Inc. (INMB:NASDAQ), powered by AI.

Current Price
$1.28
Sector
Healthcare
What is the Inmune Bio Inc. stock price forecast?

Inmune Bio Inc. is currently trading at $1.28. View real-time AI analysis on Alpha Lenz.

What is Inmune Bio Inc. insider trading activity?

View the latest insider trading data for Inmune Bio Inc. on Alpha Lenz.

What is Inmune Bio Inc.'s P/E ratio?

View Inmune Bio Inc.'s valuation metrics on Alpha Lenz.

Inmune Bio Inc.

NASDAQ · INMB
$1.28+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Inmune Bio Inc.'s future dividend policy...
Alpha Chat Insight

Inmune Bio Inc.'s ROE is -165.2%. Explore profitability and growth together.

Ask for details

Company Overview

Inmune Bio Inc. is a biotechnology company focused on the development of innovative therapies for modulating the immune system. The primary purpose of its research and development efforts is to create treatments that help in managing and potentially curing a range of conditions by targeting innate immune functions. This approach is significant in the medical field, particularly in autoimmune diseases, cancer, and neurodegenerative disorders, where the immune system's regulation can have profound impacts on disease progression and patient outcomes. By harnessing the body's own defense mechanisms, Inmune Bio Inc. aims to advance therapeutic solutions that are both effective and minimize adverse side effects. Operating in a rapidly evolving sector, the company holds an influential role in the biotechnology market, contributing to cutting-edge scientific advancements. By fostering collaborations with research institutions and leveraging its proprietary technologies, Inmune Bio Inc. continues to push the boundaries of immune-based treatments, offering hope for novel applications across different medical conditions.

CEOMr. David J. Moss M.B.A.
SectorHealthcare
IndustryBiotechnology
Employees13

Company Statistics

FY 2025

Profile

N/AMarket Cap
$50.00KRevenue
0.00Shares Out
13Employees

Margins

N/AGross
-28542.00%EBITDA
-61738.00%Operating
-91866.00%Pre-Tax
-91866.00%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-48.87%Rev 3Yr
35.37%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-127.75%ROA
-165.16%ROE
-85.85%ROIC

Financial Health

$24.75MCash & Cash Equivalents
$-15.92MNet Debt
37.52%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Inmune Bio Inc. (ticker: INMB) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 13 employees.

The current price is $1.28 with a P/E ratio of -x and P/B of -x.

ROE is -165.16% and operating margin is -61738.00%. Annual revenue is $50,000.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Inmune Bio Inc. (INMB) Stock Forecast 2026 $1.28 — Price, Financials & Analyst Targets | Alpha Lenz